Table 4.

Adverse events in chemo-radiotherapy plus nimotuzumab (Arm A) and chemo-radiotherapy (Arm B) treatment group

Incidence of adverse events	Arm
	Nimotuzumab (n=15), n (%)	CTRT (n=14), n (%)
Anemia	15 (100.0)	14 (77.8)
Leukopenia	15 (100.0)	13 (72.2)
Skin reaction	15 (100.0)	14 (77.8)
Anorexia	15 (100.0)	14 (77.8)
Hypomagnesemia (<1.8 mg/dl)	0 (0.0)	1 (5.6)
Skin rash	0 (0.0)	0 (0.0)
Dysphagia	15 (100.0)	14 (77.8)
Mucositis	15 (100.0)	14 (77.8)
Salivary gland changes	14 (93.3)	9 (50.0)
Weight loss	14 (93.3)	14 (77.8)
Alopecia	15 (100.0)	14 (77.8)

CTRT=Chemoradiotherapy